⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockSwitzerlandNYSE

NVS

Novartis AG

Healthcare · Drug Manufacturers - General

137.48USD

-0.2200 (-0.16%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 137.48
P/E20.5
Dvd Ind Yld3.4%
P/B6.29
P/S4.6
Curr EV/T12M EBITDA13.4
Mkt Cap (USD)261.3B
Curr EV (USD)303.1B
2)

Per Share Data

EPS T12M6.63
DPS8.82
Bk Val Per Sh21.86
Rev/Sh29.62
Cash/Sh4.01
Curr Shares Out1,900.7M
FCF/Sh7.83
3)

Cash Flow Analysis

P/CF14.2
Curr P/FCF17.4
CF/NI1.4
Dvd P/O132.4%
Cash Gen/Cash Reqd0.9
Csh Dvd Cov1.1
CFO/Sales32.4%
Eff Interest Rate3.6%
4)

Growth Potential

Dil EPS 1Y Gr21.8%
Cap 1Y Gr8.3%
BPS 1Y Gr9.0%
R&D To Sales20.6%
Retention Rate-32.4%
Rev 1Y Gr9.6%
FCF 1Y Gr10.4%
Assets 1Y Gr8.5%
5)

Profitability

EBITDA22.6B
EBIT17.1B
Operating Margin30.2%
Pretax Margin27.4%
Net Margin22.5%
ROA11.3%
ROE30.5%
ROC15.8%
Asset Turnover0.50
6)

Structure

Current Ratio0.86
Quick Ratio0.55
Debt/Assets38.6%
Debt/Com Eq113.3%
Net Debt/EBITDA1.74
Tot Debt/Capital53.1%
Gross Margin74.7%
EBIT/Int Exp12.3

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.